These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4276488)

  • 1. Role of endocrine factors in the pathogenesis of cardiac hypertrophy.
    Cohen J
    Circ Res; 1974 Aug; 35(2):suppl II:49-57. PubMed ID: 4276488
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cardiac lesions in endocrine diseases].
    Eliseev OM; Khil'kin AM
    Ter Arkh; 1976; 48(4):134-48. PubMed ID: 136052
    [No Abstract]   [Full Text] [Related]  

  • 3. Growth hormone in cardiac hypertrophy induced by nephrogenous hypertension.
    Powis RL
    Recent Adv Stud Cardiac Struct Metab; 1975; 8():413-25. PubMed ID: 129836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations between adrenal weight and heart weight in rats with a cardiac overload.
    Schreiber V; Kölbel F; Stĕpán J; Pribyl T; Jahodová J; Kubová V
    Physiol Bohemoslov; 1981; 30(4):289-94. PubMed ID: 6458048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of cardiac hypertrophy on arterial and cardiopulmonary baroreflex control of renal sympathetic nerve activity in anaesthetized rats.
    Flanagan ET; Buckley MM; Aherne CM; Lainis F; Sattar M; Johns EJ
    Exp Physiol; 2008 Sep; 93(9):1058-64. PubMed ID: 18487313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myocardial fluorescence of catecholamines in experimental heart hypertrophy].
    Stegmann T; Rebel W
    Med Welt; 1975 May; 26(19):950-5. PubMed ID: 124384
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the pathogenesis of hypertension in endocrine disorders].
    Fischer V
    Praxis; 1967 Oct; 56(43):1465-73 concl. PubMed ID: 5633074
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of redox signaling in cardiac hypertrophy induced by experimental hyperthyroidism.
    Araujo AS; Schenkel P; Enzveiler AT; Fernandes TR; Partata WA; Llesuy S; Ribeiro MF; Khaper N; Singal PK; Belló-Klein A
    J Mol Endocrinol; 2008 Dec; 41(6):423-30. PubMed ID: 18787053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diabetes secondary to endocrine diseases].
    Löffler J; Blanc MH
    Rev Med Suisse Romande; 1995 Sep; 115(9):721-6. PubMed ID: 7481361
    [No Abstract]   [Full Text] [Related]  

  • 10. Heterogeneity of contractile function in cardiac hypertrophy.
    Skelton CL; Sonnenblick EH
    Circ Res; 1974 Aug; 35(2):suppl II:83-96. PubMed ID: 4276492
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of sodium houttuyfonate on myocardial hypertrophy in mice and rats.
    Gao JP; Chen CX; Wang Y; Lü J; Gu WL
    J Pharm Pharmacol; 2009 May; 61(5):677-83. PubMed ID: 19406008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of the aldosterone antagonist spironolactone to inhibit myocardial hypertrophy produced by experimental hyperthyroidism and accompanied by "apparent" digoxin immunoreactivity in the blood.
    Schreiber V; Stĕpan J; Kölbel F; Pribyl T; Jahodová J; Kubová V
    Physiol Bohemoslov; 1980; 29(6):577-9. PubMed ID: 6451886
    [No Abstract]   [Full Text] [Related]  

  • 13. Protein fractions and antigens of the heart muscle in isoproterenol induced cardiac hypertrophy.
    Iazigian A; Lapohos E; Szabó S
    Arch Roum Pathol Exp Microbiol; 1976 Dec; 35(4):363-72. PubMed ID: 143922
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased myocardial cathepsin D activity during regression of thyrotoxic cardiac hypertrophy.
    Wildenthal K; Mueller EA
    Nature; 1974 May; 249(456):478-9. PubMed ID: 4276029
    [No Abstract]   [Full Text] [Related]  

  • 15. Decreased baroreflex sensitivity in isoproterenol-treated mice with cardiac hypertrophy.
    Gava AL; Peotta VA; Cabral AM; Meyrelles SS; Vasquez EC
    Auton Neurosci; 2004 Jul; 114(1-2):47-54. PubMed ID: 15331044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental cardiac hypertrophy in rats].
    Swynghedauw B; Courtault D; Wanstok F
    Pathol Biol; 1968; 16(11):691-4. PubMed ID: 4234560
    [No Abstract]   [Full Text] [Related]  

  • 17. Heart-specific inhibition of protooncogene c-myc attenuates cold-induced cardiac hypertrophy.
    Bello Roufai M; Li H; Sun Z
    Gene Ther; 2007 Oct; 14(19):1406-16. PubMed ID: 17637797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The heart in acromegaly: correlation of echocardiographic and clinical findings.
    Luboshitzki R; Hammerman H; Barzilai D; Markiewicz W
    Isr J Med Sci; 1980 May; 16(5):378-83. PubMed ID: 6447120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discussion: Pathogenesis of cardiac hypertrophy.
    Circ Res; 1974 Aug; 35(2):suppl II:104-15. PubMed ID: 4276494
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of modern components of the mechanism of cardiac hypertrophy.
    Meerson FZ
    Circ Res; 1974 Aug; 35(2):suppl II:58-63. PubMed ID: 4276489
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.